- 询价
- 玉博
- 玉博
- 2025年07月14日
12 年钻石会员
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
【简单介绍】
list biological laboratories公司是世界著名的科研毒素试剂供应商，其毒素包括霍乱病毒，蛇毒，百日咳毒素等各类毒素,我公司常年低价供应,货期快.有意者请联系【详细说明】
list biological laboratories公司是世界著名的科研毒素试剂供应商，其毒素包括霍乱病毒，蛇毒，百日咳毒素等各类毒素,我公司常年低价供应,货期快.有意者请联系. 百日咳毒素长期现货供应，货号181及180
| 分类 | 货号 | 产品名称 | 规格 |
| Anthrax toxins | 169A | Anthrax Lethal Factor （LF）, Native Sequence from Bacillus anthracis |
0.1mg |
| Anthrax toxins | 169B | Anthrax Lethal Factor （LF）, Native Sequence from Bacillus anthracis | 1mg |
| Anthrax toxins | 171A | Anthrax Protective Antigen （PA）, Recombinant from Bacillus anthracis |
0.1mg |
| Anthrax toxins | 171B | Anthrax Protective Antigen （PA）, Recombinant from Bacillus anthracis | 1mg |
| Anthrax toxins | 171C | Anthrax Protective Antigen （PA）, Recombinant from Bacillus anthracis | 10mg |
| Anthrax toxins | 172A | Anthrax Lethal Factor （LF）, Recombinant from Bacillus anthracis |
0.1mg |
| Anthrax toxins | 172B | Anthrax Lethal Factor （LF）, Recombinant from Bacillus anthracis | 1mg |
| Anthrax toxins | 172C | Anthrax Lethal Factor （LF）, Recombinant from Bacillus anthracis | 10mg |
| Anthrax toxins | 173B | Anthrax Edema Factor （EF）, Recombinant, Mutant S447N from Bacillus anthracis | 0.5mg |
| Anthrax toxins | 174 | Anthrax Protective Antigen, Activated （PA 63） from Bacillus anthracis | 0.5mg |
| Anthrax toxins | 175 | Anthrax PA 63 - Fluorescein Isothiocyanate Conjugate （PAFITC） | 50 ug |
| Anthrax toxins | 176A | Inactive Mutant Lethal Factor （LF）, Recombinant from Bacillus anthracis | 0.1mg |
| Anthrax toxins | 176B | Inactive Mutant Lethal Factor （LF）, Recombinant from Bacillus anthracis | 1mg |
| Anthrax toxins | 177A | Anthrax Protective Antigen Fragment （PA 20） from Bacillus anthracis |
50ug |
| Anthrax toxins | 177B | Anthrax Protective Antigen Fragment （PA 20） from Bacillus anthracis | 0.25mg |
| Anthrax toxins | 178A | Anthrax Edema Factor （EF）, Recombinant from Bacillus anthracis | 0.1mg |
| Anthrax toxins | 178B | Anthrax Edema Factor （EF）, Recombinant from Bacillus anthracis | 0.5mg |
| Anthrax toxins | 440A | CELL Wall from Bacillus anthracis | 5mg |
| Anthrax toxins | 440B | CELL Wall from Bacillus anthracis | 50mg |
| Anthrax toxins | 9171A | QD Anthrax Protective Antigen （PA）, Recombinant from Bacillus anthracis |
0.1mg |
| Anthrax toxins | 9171B | QD Anthrax Protective Antigen （PA）, Recombinant from Bacillus anthracis | 1mg |
| Anthrax toxins | 9172A | QD Anthrax Lethal Factor （LF）, Recombinant from Bacillus anthracis |
0.1mg |
| Anthrax toxins | 9172B | QD Anthrax Lethal Factor （LF）, Recombinant from Bacillus anthracis | 1mg |
| Anthrax toxins | 9172C | QD Anthrax Lethal Factor （LF）, Recombinant from Bacillus anthracis | 10mg |
| Botulinum toxins | 128A | Botulinum Neurotoxin Type A Complex from Clostridium botulinum |
10ug |
| Botulinum toxins | 128C | Botulinum Neurotoxin Type A Complex from Clostridium botulinum | 100ug |
| Botulinum toxins | 130A | Botulinum Neurotoxin Type A from Clostridium botulinum | 10ug |
| Botulinum toxins | 130B | Botulinum Neurotoxin Type A from Clostridium botulinum | 100ug |
| Botulinum toxins | 133A | Botulinum Neurotoxin Type A Toxoid |
10ug |
| Botulinum toxins | 133B | Botulinum Neurotoxin Type A Toxoid | 50ug |
| Botulinum toxins | 136A | Botulinum Neurotoxin Type B, Nicked, from Clostridium botulinum |
10ug |
| Botulinum toxins | 136B | Botulinum Neurotoxin Type B, Nicked, from Clostridium botulinum | 100ug |
| Botulinum toxins | 138A | Botulinum Neurotoxin Type B Complex, Nicked, from Clostridium botulinum |
10ug |
| Botulinum toxins | 138B | Botulinum Neurotoxin Type B Complex, Nicked, from Clostridium botulinum | 100ug |
| Botulinum toxins | 139 | Botulinum Neurotoxin Type B Toxoid | 10ug |
| Botulinum toxins | 140A | Botulinum Neurotoxin Type E, Nicked, Complex from Clostridium botulinum |
10ug |
| Botulinum toxins | 140B | Botulinum Neurotoxin Type E, Nicked, Complex from Clostridium botulinum | 100ug |
| Botulinum toxins | 141A | Botulinum Neurotoxin Type E, Nicked, from Clostridium botulinum |
10ug |
| Botulinum toxins | 141B | Botulinum Neurotoxin Type E, Nicked, from Clostridium botulinum | 100ug |
| Botulinum toxins | 143 | Exoenzyme C3 from Clostridium botulinum | 50ug |
| Botulinum toxins | 610A | Botulinum Neurotoxin Type A Light Chain, Recombinant | 10ug |
| Botulinum toxins | 611A | Botulinum Neurotoxin Type A Light Chain, Recombinant, GST Fusion | 15ug |
| Botulinum toxins | 612A | Botulinum Neurotoxin Type A Heavy Chain, Recombinant, Binding Domain | 50ug |
| Botulinum toxins | 613A | Botulinum Neurotoxin Type A GST Heavy Chain, Recombinant, Binding Domain | 50ug |
| Botulinum toxins | 620A | Botulinum Neurotoxin Type B Light Chain, Recombinant | 10ug |
| Botulinum toxins | 622A | Botulinum Neurotoxin Type B Heavy Chain, Recombinant, Binding Domain | 50ug |
| Botulinum toxins | 623A | Botulinum Neurotoxin Type B GST Heavy Chain, | 50ug |
| Botulinum toxins | 625A | Botulinum Neurotoxin Type C Light Chain, Recombinant | 10ug |
| Botulinum toxins | 630A | Botulinum Neurotoxin Type E Light Chain, Recombinant | 10ug |
| Botulinum toxins | 635A | Botulinum Neurotoxin Type E Light Chain, Recombinant | 10ug |
| Botulinum toxins | 640B | Botulinum Neurotoxin Type F Light Chain, Recombinant | 100ug |
| Botulinum toxins | 9128A | QD Botulinum Neurotoxin Type A Complex from Clostridium botulinum | 10ug |
| Botulinum toxins | 9128B | QD Botulinum Neurotoxin Type A Complex from Clostridium botulinum | 100ug |
| Botulinum toxins | 9130A | QD Botulinum Neurotoxin Type A from Clostridium botulinum | 10ug |
| Botulinum toxins | 9130B | QD Botulinum Neurotoxin Type A from Clostridium botulinum | 100ug |
| Cholera toxin | 100B | Cholera Toxin （AZIDE-FREE） | 1mg |
| Cholera toxin | 101A | Cholera Toxin | 0.5mg |
| Cholera toxin | 101B | Cholera Toxin | 1mg |
| Cholera toxin | 101C | Cholera Toxin | 2mg |
| Cholera toxin | 102B | Cholera Toxin A Subunit | 0.25mg |
| Cholera toxin | 103B | Cholera Toxin B Subunit （Choleragenoid） | 1mg |
| Cholera toxin | 103C | Cholera Toxin B Subunit （Choleragenoid） | 2mg |
| Cholera toxin | 104 | Cholera Toxin B Subunit （Choleragenoid） in Low Salt | 0.5mg |
| Cholera toxin | 105 | Cholera Toxin B Subunit - Horseradish Peroxidase Conjugate （BHRP） | 0.1mg |
| Cholera toxin | 106 | Cholera Toxin B Subunit Fluorescein Isothiocyanate Conjugate （BFITC） | 0.2mg |
| Cholera toxin | 107 | Cholera Toxin B Subunit Tetramethyl Rhodamine Conjugate （BTRITC） | 0.2mg |
| Cholera toxin | 112 | Cholera Toxin B Subunit Biotin Conjugate （BB） | 0.2mg |
| Difficile Toxins | 152A | Toxin A from Clostridium difficile | 2ug |
| Difficile Toxins | 152B | Toxin A from Clostridium difficile | 25ug |
| Difficile Toxins | 152C | Toxin A from Clostridium difficile | 100ug |
| Difficile Toxins | 153 | Toxin A Toxoid from Clostridium difficile | 100ug |
| Difficile Toxins | 154A | Toxin B from Clostridium difficile | 20ug |
| Difficile Toxins | 154B | Toxin B from Clostridium difficile | 100ug |
| Difficile Toxins | 155A | Toxin B from Clostridium difficile | 2ug |
| Difficile Toxins | 155B<, /FONT> | Toxin B from Clostridium difficile | 20ug |
| Difficile Toxins | 155C | Toxin B from Clostridium difficile | 200ug |
| Diphtheria Toxin | 149 | Diphtheria Toxin CRM Mutant | 1mg |
| Diphtheria Toxin | 150 | Diphtheria Toxin （unnicked） | 1mg |
| Diphtheria Toxin | 151 | Diphtheria Toxoid | 0.5mg |
| Fret peptides and native substrates | 500A | SNAP-25 Recomb Protein Substrate for C. botulinum Types A and E Neurotoxin | 100ug |
| Fret peptides and native substrates | 510A | GST Synaptobrevin-2 Recomb Protein Substrate for C. botulinum Types B, D, F and G | 100ug |
| Fret peptides and native substrates | 520 | SNAPtide® Peptide Substrate （o-Abz/Dnp） for Clostridium botulinum Type A Neurotoxin | 200nmol |
| Fret peptides and native substrates | 521 | SNAPtide® Peptide Substrate （FITC/DABCYL） for Clostridium botulinum | 200nmol |
| Fret peptides and native substrates | 525 | Control Peptide for SNAPtide® 520 | 200nmol |
| Fret peptides and native substrates | 528 | Unquenched Calibration Peptide for SNAPtide® 521 | 50nmol |
| Fret peptides and native substrates | 529 | Unquenched Calibration Peptide for SNAPtide® 520 | 50nmol |
| Fret peptides and native substrates | 530 | MAPKKide® Peptide Substrate （o-Abz/Dnp） for Anthrax Lethal Factor | 200nmol |
| Fret peptides an, d native substrates | 531 | MAPKKide® Peptide Substrate （DABCYL/FITC） for Anthrax Lethal Factor | 200nmol |
| Fret peptides and native substrates | 539 | MAPKKide® Unquenched Calibration Peptide for 530 for Anthrax Lethal Factor | 50nmol |
| Fret peptides and native substrates | 540 | VAMPtide® Peptide Substrate （o-Abz/Dnp） | 200nmol |
| Fret peptides and native substrates | 541 | VAMPtide® Peptide Substrate （FITC/DABCYL） | 200nmol |
| Fret peptides and native substrates | 549 | CALIBRATION FLUOROPHORE for VAMPtide® 540 | 100nmol |
| Fret peptides and native substrates | 550 | SNAP Etide® Peptide Substrate （o-Abz/Dnp） for C. botulinum Type E Neurotoxin | 150nmol |
| Fret peptides and native substrates | 560 | SYNTAXtide® （o-Abz/Dnp） Peptide Substrate for C. botulinum Type C Neurotoxin | 200nmol |
| Lipopolysaccharides（LPS） | 201 | LPS from Escherichia coli O111:B4 | 5mg |
| Lipopolysaccharides（LPS） | 203 | LPS from Escherichia coli O55:B5 | 5mg |
| Lipopolysaccharides（LPS） | 206 | LPS from Escherichia coli 0157:H7 | 10mg |
| Lipopolysaccharides（LPS） | 225 | LPS from Salmonella typhimurium | 5mg |
| Lipopolysaccharides（LPS） | 301 | LPS from Escherichia coli J5 （Rc） | 5mg |
| Lipopolysaccharides（LPS） | 302 | LPS from Escherichia coli K12, D31m4 （Re） | 5mg |
| Lipopolysaccharides（LPS） | 304 | LPS from Salmonella minnesota R595 （Re） | 5mg |
| Lipopolysaccharides（LPS） | 314 | LPS from Escherichia coli K12 strain LCD25 | 1mg |
| Lipopolysaccharides（LPS） | 401 | LIPID A （primarily monophosphoryl） from Salmonella minnesota R595 | 1mg |
| Lipopolysaccharides（LPS） | 402 | LIPID A （primarily diphosphoryl） from Escherichia coli K12, D31m4 | 1mg |
| Lipopolysaccharides（LPS） | 421 | ULTRA PURE LPS from Escherichia coli O111:B4 | 1mg |
| Lipopolysaccharides（LPS） | 423 | ULTRA PURE LPS from Escherichia coli 055:B5 | 1mg |
| Lipopolysaccharides（LPS） | 434 | ULTRA PURE LPS from Salmonella minnesota R595 （Re） | 1mg |
| Other toxins | 120 | Alpha Toxin from Staphylococcus aureus | 0.25mg |
| Other toxins | 122 | Enterotoxin Type B from Staphylococcus aureus | 0.5mg |
| Other toxins | 156 | Pasteurella Multocida Toxin | 50ug |
| Other toxins | 160 | Exotoxin A from Pseudomonas aeruginosa | 1mg |
| Other toxins | 165B | HEAT LABILE TOXIN from Escherichia coli | 0.5mg |
| Other toxins | 188 | Adenylate Cyclase Toxin from B. pertussis | 50ug |
| Other toxins | 199 | Tetanolysin from C. tetani | 100ug |
| Pertussis Toxins | 170 | Filamentous Hemagglutinin （FHA） | 50ug |
| Pertussis Toxins | 179A | Pertussis Toxin Islet Activating Protein （in Glycerol） | 50ug |
| Pertussis Toxins | 179B | Pertussis Toxin Islet Activating Protein （in Glycerol） | 200ug |
| Pertussis Toxins | 180 | Pertussis Toxin Islet Activating Protein, Lyophilized in Buffer | 50ug |
| Pertussis Toxins | 181 | Pertussis Toxin Islet Activating Protein, Lyophilized （Salt-Free） | 50ug |
| Pertussis Toxins | 182 | Pertussis Toxin A Protomer | 10ug |
| Pertussis Toxins | 183 | Pertussis Toxin B Oligomer | 40ug |
| Shiga like Toxins | 161 | Shiga Toxin 1 from E. coli recombinant | 10ug |
| Shiga like Toxins | 162 | Shiga Toxin 2 from E. coli recombinant | 10ug |
| Shiga like Toxins | 164 | Shiga Toxin 2 （verotoxin 2） from E. coli O157 | 10ug |
| Tetanus Toxins | 190A | Tetanus Toxin | 25ug |
| Tetanus Toxins | 190B | Tetanus Toxin | 100ug |
| Tetanus Toxins | 191A | Tetanus Toxoid | 25ug |
| Tetanus Toxins | 191B | Tetanus Toxoid | 100ug |
| Tetanus Toxins | 193 | Tetanus Toxin C Fragment | 10ug |
| Tetanus Toxins | 196A | Tetanus Toxin C Fragment Fluorescein Isothiocyanate Conjugate （CFITC） | 10ug |
| Tetanus Toxins | 650A | Tetanus Toxin Light Chain, Recombinant | 10ug |
| Antisera and Antibodies | 703 | Anti-Cholera Toxin B Subunit （Goat） | 0.1ml |
| Antisera and Antibodies | 730A | Antti-Botulinum Neurotoxin Type A（Chicken lgY） | 0.1mg |
| Antisera and Antibodies | 736A | Anti-Botulinum Type B（Chicken lgY） | 0.1mg |
| Antisera and Antibodies | 752 | Anti-Toxin A from Clostridium difficile （Goat） | 0.5ml |
| Antisera and Antibodies | 753A | Anti-Clostridium difficile Toxin A （Chicken lgY） | 0.1mg |
| Antisera and Antibodies | 760 | Anti-Exotoxin A （Goat） | 1ml |
| Antisera and Antibodies | 763 | Anti-Shiga Toxin 1 from E. Coli （Mouse IgG1-κ） monoclonal | 100ug |
| Antisera and Antibodies | 764 | Anti-Shiga Toxin 2 from E. Coli （Mouse IgG1-κ） monoclonal | 100ug |
| Antisera and Antibodies | 771B | Anti-Protective Antigen from Bacillius anthracis （Goat） | 1mg |
| Antisera and Antibodies | 772B | Anti-Lethal Factor from Bacillius anthracis （Goat） | 1mg |
| Antisera and Antibodies | 773B | Anti-Edema Factor from Bacillius anthracis （Goat） | 1mg |
Ambion| http://www.ybiotechmall.com/enstyle/firstcatalog_3294133_Ambion_1.html;
Amnis| http://www.ybiotechmall.com/enstyle/firstcatalog_3294134_Amnis_1.html;
Amaxa| http://www.ybiotechmall.com/enstyle/firstcatalog_3294135_Amaxa_1.html;
acris-antibodies| http://www.ybiotechmall.com/enstyle/firstcatalog_3294136_acris-antibodies_1.html;
Acrometrix| http://www.ybiotechmall.com/enstyle/firstcatalog_3294137_Acrometrix_1.html;
Axis-shield| http://www.ybiotechmall.com/enstyle/firstcatalog_3294138_Axis-shield_1.html;
Antigenix| http://www.ybiotechmall.com/enstyle/firstcatalog_3294139_Antigenix_1.html;
Addgene| http://www.ybiotechmall.com/enstyle/firstcatalog_3294140_Addgene_1.html;
ADI| http://www.ybiotechmall.com/enstyle/firstcatalog_3294141_ADI_1.html;
Alpha Diagnoestic International| http://www.ybiotechmall.com/enstyle/firstcatalog_3294142_Alpha-Diagnoestic-International_1.html;
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
Kinetic Modeling of Biological Systems
with the aim of improving our understanding of the studied system. Due to the unique properties of biological systems, in addition to the usual difficulties faced in modeling the dynamics of physical or chemical systems, biological simulations encounter
Isolation, Separation, and Analysis of Phosphoinositides from Biological Sources
of these lipids makes conventional lipid extraction and assay procedures unsuitable for their analysis. Hence, specific analytical procedures have been devised in a number of laboratories for the quantitative extraction, separation, and assay of this class
Biochemical and Molecular Biological Assessments of Intracerebral Hemorrhage
injury and severe neurological deficits. In an effort to understand the underlying mechanisms of ICH-induced brain injury and to evaluate therapeutic interventions, numerous experimental studies have been performed in our laboratories in last years
技术资料暂无技术资料 索取技术资料
list biological laboratories产品介绍
询价
